The association between CKD-associated pruritus and quality of life in patients undergoing hemodialysis in Pakistan

Rehman, Inayat Ur; Chan, Kok‐Gan; Munib, Syed; Lee, Learn‐Han; Khan, Tahir Mehmood

doi:10.1097/md.0000000000016812

Cited by 16 publications

(27 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The DOPPS recruited 51 062 participants from 21 countries across five study phases (DOPPS 1–5) between 1996 and 2015 [ 10 ] and 23 264 participants across DOPPS 4–6 between 2009 and 2018 [ 11 ]. Patients were asked to self-report via questionnaire the presence and severity of pruritus over a 4-week period.…”

Section: Epidemiology Of Ckd-apmentioning

confidence: 99%

“…The proportion of patients with moderate to extreme itch in DOPPS 1 and 2 (45 and 42%, respectively) was similar to that in DOPPS 4–6, where the overall prevalence of moderate to extreme itch was 37%, with no significant difference across study phases [ 8 ]. One reported difference was that participants noted less severe itch in DOPPS 5 (2012–2015) compared with DOPPS 1 (1996–2001) [ 10 ], which may suggest improvements in managing CKD-aP over time. A study of the Japanese DOPPS cohort (JDOPPS) showed that overall, 44% of patients experienced moderate to extreme pruritus, but the prevalence varied widely across centres, ranging from 20% to 70% [ 17 ].…”

Section: Epidemiology Of Ckd-apmentioning

confidence: 99%

“…However, this is an area of research interest, based on evidence of sex-specific differences in itch-related mechanisms, including mast cell activation and regulation of the opioid cannabinoid and the neurokinin 1 systems [ 1 ]. A number of observational studies, including DOPPS, have shown a greater prevalence of CKD-aP in males undergoing HD [ 3 , 10 ]. However, Ramakrishnan et al [ 16 ] found a higher prevalence of pruritus in females.…”

Section: Potential Risk Factors For Ckd-ap In Dialysis Patientsmentioning

confidence: 99%

See 2 more Smart Citations

Epidemiology and burden of chronic kidney disease-associated pruritus

Kim

Pollock

2021

Clinical Kidney Journal

View full text Add to dashboard Cite

Chronic kidney disease–associated pruritus (CKD-aP) is a common, yet underrecognized condition in patients with CKD and end-stage kidney disease (ESKD). Real-world observational studies indicate that CKD-aP affects up to 80% of ESKD patients undergoing haemodialysis (HD), with ∼40% experiencing moderate to severe itch. CKD-aP can negatively impact patients’ mental and physical health-related quality of life (HRQoL) and is also associated with sleep disturbance and depression. Several studies have found that CKD-aP is a predictor of adverse medical outcomes, including an increased risk of hospitalizations and mortality. In this article we review the literature relating to the epidemiology of CKD-aP to describe its prevalence across the treatment spectrum of CKD (non-dialysis, HD, peritoneal dialysis and transplant recipients) and to summarize potential risk factors associated with its development. We also review key data from studies that have evaluated the impact of CKD-aP on HRQoL and medical outcomes.

show abstract

Section: Epidemiology Of Ckd-apmentioning

confidence: 99%

Section: Epidemiology Of Ckd-apmentioning

confidence: 99%

Section: Potential Risk Factors For Ckd-ap In Dialysis Patientsmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiology and burden of chronic kidney disease-associated pruritus

Kim

Pollock

2021

Clinical Kidney Journal

View full text Add to dashboard Cite

show abstract

“…In addition, several previous studies have acknowledged similar patient profiles. 4 , 10 , 15 , 16 Therefore, those on treatment for a longer time are assumed to have better discipline in observing the schedule, despite some impending obstacles. This disposition resulted from the benefits perceived from participating in therapy sessions.…”

Section: Discussionmentioning

confidence: 99%

Characteristics of patients undergoing hemodialysis during Covid-19 pandemic

2021

View full text Add to dashboard Cite

“…STS can cause side effects, such as severe but transient nausea and vomiting [50]. Mild hypernatremia, hypokalemia, or hypocalcemia (not significant) or a mild increase in the corrected QT interval (not significant) might also be side effects [51]. Another study demonstrated that neither potassium nor sodium accumulated in the circulating blood when STS was infused in conjunction with HD [52].…”

Section: Discussionmentioning

confidence: 99%

Therapeutic effect of intravenous sodium thiosulfate for uremic pruritus in hemodialysis patients

et al. 2020

View full text Add to dashboard Cite

Objectives: This study aimed to compare the efficacy of intravenous sodium thiosulfate (IV STS) with that of loratadine in the treatment of uremic pruritus in hemodialysis (HD) patients. Methods: This retrospective study included 44 HD patients with pruritus aged over 18 years between June 2018 and January 2020 at the Aerospace Center Hospital of China. Twenty-four HD patients received 3.2 g IV STS treatment three times per week at the end of each HD session for 8 weeks. Twenty HD patients received loratadine (10 mg/day) for 8 weeks. Pruritus intensity was measured using a visual analog scale (VAS) and the detailed pruritus score (DPS) at three time points. The safety of STS was evaluated according to adverse event symptoms and biological variable changes. Results: There was no significant difference between the STS and loratadine groups in age, sex, characteristics of pruritus, or other clinical variables before treatment. After 8 weeks of treatment, the VAS score (7.07 ± 2.56 and 2.67 ± 2.01) and DPS (30.72 ± 4.81 and 8.04 ± 2.86) decreased significantly in the STS group (p < 0.05). The mean decrease in VAS score (6.89 ± 1.98 and 6.34 ± 2.35) and DPS (28.90 ± 3.24 and 26.92 ± 2.41) in the loratadine group was not statistically significant (p > 0.05). There were no morbidities or mortalities associated with the use of either drug. All biological variables remained stable after therapy. Conclusions: STS can improve uremic pruritus in HD patients. However, literature on the subject remains lacking. Close monitoring for adverse effects is advised.

show abstract

The association between CKD-associated pruritus and quality of life in patients undergoing hemodialysis in Pakistan

Abstract: Supplemental Digital Content is available in the text

Cited by 16 publications

References 34 publications

Epidemiology and burden of chronic kidney disease-associated pruritus

Epidemiology and burden of chronic kidney disease-associated pruritus

Characteristics of patients undergoing hemodialysis during Covid-19 pandemic

Therapeutic effect of intravenous sodium thiosulfate for uremic pruritus in hemodialysis patients

Contact Info

Product

Resources

About